Marlan D. Walker's most recent trade in TherapeuticsMD Inc was a trade of 67,492 Non-Qualified Stock Option (right to buy) done . Disclosure was reported to the exchange on Nov. 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| TherapeuticsMD Inc | Marlan D. Walker | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2025 | 67,492 | 67,492 | - | - | Non-Qualified Stock Option (right to buy) | |
| TherapeuticsMD Inc | Marlan D. Walker | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 14 Apr 2025 | 490 | 73,639 (0%) | 0% | 1.0 | 489 | Common Stock |
| TherapeuticsMD Inc | Marlan D. Walker | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.86 per share. | 09 Apr 2025 | 1,167 | 73,149 (0%) | 0% | 0.9 | 1,000 | Common Stock |
| TherapeuticsMD Inc | Marlan D. Walker | Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.88 per share. | 09 Apr 2025 | 1,136 | 71,982 (0%) | 0% | 0.9 | 994 | Common Stock |
| TherapeuticsMD Inc | Marlan D. Walker | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 3,467 | 66,032 (0%) | 0% | 0 | Common Stock | |
| TherapeuticsMD Inc | Marlan D. Walker | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 3,467 | 0 | - | - | Performance Stock Units | |
| TherapeuticsMD Inc | Marlan D. Walker | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 2,311 | 68,343 (0%) | 0% | 0 | Common Stock | |
| TherapeuticsMD Inc | Marlan D. Walker | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 2,311 | 0 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Marlan D. Walker | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 1,733 | 1,733 | - | - | Restricted Stock Units | |
| TherapeuticsMD Inc | Marlan D. Walker | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 1,733 | 70,846 (0%) | 0% | 0 | Common Stock | |
| TherapeuticsMD Inc | Marlan D. Walker | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 770 | 69,113 (0%) | 0% | 0 | Common Stock | |
| TherapeuticsMD Inc | Marlan D. Walker | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2025 | 770 | 0 | - | - | Restricted Stock Units |